...
首页> 外文期刊>International Journal of Cardiology >A single, comprehensive non-invasive cardiovascular assessment in pulmonary arterial hypertension: combined computed tomography pulmonary and coronary angiography.
【24h】

A single, comprehensive non-invasive cardiovascular assessment in pulmonary arterial hypertension: combined computed tomography pulmonary and coronary angiography.

机译:一项针对肺动脉高压的综合性非侵入性心血管评估:计算机断层扫描肺动脉造影和冠状动脉造影检查。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Comprehensive assessment of pulmonary arterial hypertension (PAH) should identify structural causes and subsequent cardiopulmonary consequences of PAH. This currently requires the use of several imaging modalities. Computed tomography (CT) is routinely used for pulmonary angiography (CTPA). Our aim was to assess whether combined pulmonary and coronary angiography (CTPCA) using ECG-gated, multi-detector CT (MDCT) would allow satisfactory pulmonary angiography, coronary angiography and ventriculography to be combined into a single acquisition using a single imaging modality. METHODS: We assessed CTPCA in 30 consecutive adult patients (mean age 41+/-11 years) with a diagnosis of PAH. In addition to the standard assessment of lung parenchyma and pulmonary vasculature, we assessed the ability of CT to satisfactorily visualise coronary vessels and biventricular function. Functional analysis included: end-diastolic volume (EDV), end-systolic volume (EDV), stroke volume (SV) and ejection fraction (EF) and mass and these parameters were correlated with same day cardiovascular magnetic resonance (CMR). RESULTS: Lung parenchyma, pulmonary and coronary vessels were fully visualised in all cases. Ventriculography correlated well with same day CMR (RVEDV r=0.94, +19.5+/-49.2 ml, RVESV r=0.93, +11.1+/-46.4 ml, RVSV r=0.60, +8.5+/-41.6 ml, RVEF r=0.77, -0.5+/-21.3% and RV mass r=0.73, -17.3+/-60.4 g, LVEDV r=0.68, +12.2+/-110 ml, LVESV r=0.69, +7.5+/-59.7 ml, LVSV r=0.54, +2.5+/-40.6 ml, LVEF r=0.73, -1.9+/-20.8% and LV mass r=0.87, -20.5+/-22.5 g (all p<0.001)). Associated congenital cardiovascular malformations were characterised in 22/30 cases. CONCLUSIONS: A CTPCA protocol allows safe, fast, comprehensive, non-invasive assessment of the possible anatomical causes and cardiopulmonary sequelae of PAH in adult patients, demonstrating congenital heart abnormalities, coronary artery disease and cardiac function.
机译:背景:肺动脉高压(PAH)的综合评估应确定PAH的结构性原因和随后的心肺后果。当前,这需要使用几种成像模式。计算机断层扫描(CT)通常用于肺血管造影(CTPA)。我们的目的是评估使用ECG门控多检测器CT(MDCT)进行的合并肺动脉和冠状动脉造影(CTPCA)是否可以使满意的肺血管造影,冠状动脉造影和心室造影结合成一个单一的成像方式进行单次采集。方法:我们评估了30例诊断为PAH的连续成年患者(平均年龄41 +/- 11岁)的CTPCA。除了对肺实质和肺血管系统进行标准评估外,我们还评估了CT令人满意地可视化冠状血管和双室功能的能力。功能分析包括:舒张末期容积(EDV),收缩末期容积(EDV),中风容积(SV)和射血分数(EF)和质量,这些参数与当日心血管磁共振(CMR)相关。结果:所有病例肺实质,肺和冠状血管均完全可见。心室造影与当天CMR相关性很好(RVEDV r = 0.94,+19.5 +/- 49.2 ml,RVESV r = 0.93,+11.1 +/- 46.4 ml,RVSV r = 0.60,+8.5 +/- 41.6 ml,RVEF r = 0.77,-0.5 +/- 21.3%和RV质量r = 0.73,-17.3 +/- 60.4 g,LVEDV r = 0.68,+12.2 +/- 110 ml,LVESV r = 0.69,+7.5 +/- 59.7 ml, LVSV r = 0.54,+ 2.5 +/- 40.6 ml,LVEF r = 0.73,-1.9 +/- 20.8%和LV质量r = 0.87,-20.5 +/- 22.5 g(所有p <0.001))。伴发的先天性心血管畸形的特征为22/30例。结论:CTPCA协议可对成年患者PAH的可能的解剖学原因和心肺后遗症进行安全,快速,全面,无创的评估,证明先天性心脏异常,冠状动脉疾病和心功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号